30 days ago • Posted by William Ramstein

Could big pharma stocks be value stocks now ?

The drug P/E ratio is one of the lowest among any major industry group. Indeed, the stocks haven’t been so inexpensive relative to the S&P 500 in at least 20 years, according to J.P. Morgan analyst Chris Schott. Most yield 3% or more—double the 1.5% yield on the S&P 500—with Pfizer at 4.4% and AbbVie at 4.8%. Source: MarketWatch

bg_nwsletter